SMOFKABIVEN amino acids 5.1% / lipids 3.8% / glucose 12.7% / electrolytes 0.7% emulsion for intravenous infusion bag 986 mL অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

smofkabiven amino acids 5.1% / lipids 3.8% / glucose 12.7% / electrolytes 0.7% emulsion for intravenous infusion bag 986 ml

fresenius kabi australia pty ltd - medium chain triglycerides, quantity: 60 g/l; soya oil, quantity: 60 g/l; olive oil, quantity: 50 g/l; fish oil - rich in omega-3 acids, quantity: 30 g/l - injection, intravenous infusion - excipient ingredients: sodium oleate; egg lecithin; sodium hydroxide; glycerol; dl-alpha-tocopherol; water for injections - parenteral nutrition for adult patients and paediatric patients aged 2 years and above when oral or enteral nutrition is impossible, insufficient or contraindicated.

Potassium Chloride 10 mmol in Sodium Chloride 0.9% (500 mL) নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

potassium chloride 10 mmol in sodium chloride 0.9% (500 ml)

fresenius kabi new zealand limited - potassium chloride 1.5 mg/ml;  ; sodium chloride 9 mg/ml;  ;  ;   - solution for infusion - active: potassium chloride 1.5 mg/ml   sodium chloride 9 mg/ml       excipient: hydrochloric acid sodium hydroxide water for injection - a source of water and to restore electrolyte balance as required by a patient's clinical condition, such as hypokalaemia.

Potassium Chloride 20 mmol in Sodium Chloride 0.9% (1000 mL) নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

potassium chloride 20 mmol in sodium chloride 0.9% (1000 ml)

fresenius kabi new zealand limited - potassium chloride 1.5 mg/ml;  ; sodium chloride 9 mg/ml;  ;  ;   - solution for infusion - active: potassium chloride 1.5 mg/ml   sodium chloride 9 mg/ml       excipient: hydrochloric acid sodium hydroxide water for injection - a source of water and to restore electrolyte balance as required by a patient's clinical condition, such as hypokalaemia.

Potassium Chloride 20 mmol in Sodium Chloride 0.9% (500 mL) নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

potassium chloride 20 mmol in sodium chloride 0.9% (500 ml)

fresenius kabi new zealand limited - potassium chloride 3 mg/ml;  ; sodium chloride 9 mg/ml;  ;  ;   - solution for infusion - active: potassium chloride 3 mg/ml   sodium chloride 9 mg/ml       excipient: hydrochloric acid sodium hydroxide water for injection - a source of water and to restore electrolyte balance as required by a patient's clinical condition, such as hypokalaemia.

Potassium Chloride 40 mmol in Sodium Chloride 0.9% (1000 mL) নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

potassium chloride 40 mmol in sodium chloride 0.9% (1000 ml)

fresenius kabi new zealand limited - potassium chloride 3 mg/ml;  ; sodium chloride 9 mg/ml;  ;  ;   - solution for infusion - active: potassium chloride 3 mg/ml   sodium chloride 9 mg/ml       excipient: hydrochloric acid sodium hydroxide water for injection - a source of water and to restore electrolyte balance as required by a patient's clinical condition, such as hypokalaemia.

Fresofol 1% নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

fresofol 1%

fresenius kabi new zealand limited - propofol 10 mg/ml;  ;   - emulsion for injection - 1% w/v - active: propofol 10 mg/ml     excipient: glycerol lecithin nitrogen oleic acid sodium hydroxide soya oil water for injection - a short-acting intravenous anaesthetic agent suitable for the induction and maintenance of general anaesthesia in adults and children aged three years and older. although the safety and efficacy of fresofol 1% in paediatric day surgery have not been demonstrated, it may be a useful agent in this setting and its use should not be precluded. fresofol 1% may also be used in adults for the sedation of ventilated patients receiving intensive care. fresofol 1% may also be used in adults for monitored conscious sedation for surgical and diagnostic procedures.

Glucose 10% w/v নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

glucose 10% w/v

fresenius kabi new zealand limited - glucose monohydrate 110 g/l equivalent to glucose 100 g/l;   - solution for infusion - 100 g/l - active: glucose monohydrate 110 g/l equivalent to glucose 100 g/l   excipient: hydrochloric acid sodium hydroxide water for injection - hypertonic infusion solutions are indicated: - as a source of energy incorporated with parenteral nutrition with minimal dilution effect - for use with an appropriate protein (nitrogen) source in the prevention of nitrogen loss or in the treatment of negative nitrogen balance in patients where: a) the alimentary tract cannot or should not be used. b) gastrointestinal absorption of protein is impaired. c) metabolic requirements for protein are substantially increased, as with extensive burns.

Picoprep Orange নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

picoprep orange

fresenius kabi new zealand limited - citric acid 12.2 g; magnesium carbonate monohydrate 7.4 g; sodium picosulfate 10.3mg - powder for oral solution - active: citric acid 12.2 g magnesium carbonate monohydrate 7.4 g sodium picosulfate 10.3mg excipient: orange flavour facb076 sweetener sweetesse 97 - picoprep orange is indicated for bowel emptying and cleansing by means of total gastrointestinal tract perfusion in preparation for gastrointestinal examination (such as colonoscopy, barium enema x-ray examination), prior to intravenous pyelograms (ivp) or colorectal surgery.

FLUCLOXACILLIN KABI flucloxacillin 1000 mg (as sodium) powder for injection vial অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

flucloxacillin kabi flucloxacillin 1000 mg (as sodium) powder for injection vial

fresenius kabi australia pty ltd - flucloxacillin sodium monohydrate, quantity: 1088.1 mg (equivalent: flucloxacillin, qty 1000 mg) - injection, powder for - excipient ingredients: - for the treatment of confirmed or suspected staphylococcal infections and other gram-positive coccal infections. indications include pneumonia, osteomyelitis, skin and skin structure and wound infections, infected burns and cellulitis.

FLUCLOXACILLIN KABI flucloxacillin 500 mg (as sodium) powder for injection vial অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

flucloxacillin kabi flucloxacillin 500 mg (as sodium) powder for injection vial

fresenius kabi australia pty ltd - flucloxacillin sodium monohydrate, quantity: 544.1 mg (equivalent: flucloxacillin, qty 500 mg) - injection, powder for - excipient ingredients: - for the treatment of confirmed or suspected staphylococcal infections and other gram-positive coccal infections. indications include pneumonia, osteomyelitis, skin and skin structure and wound infections, infected burns and cellulitis.